Evidence map›Paper›PMID 29066725›Full record

ArticleScientific reports2017

Heparan sulfate: Resilience factor and therapeutic target for cocaine abuse.

Jihuan Chen, Tomoya Kawamura, Manveen K Sethi, Joseph Zaia, Vez Repunte-Canonigo, Pietro Paolo Sanna

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jihuan ChenDepartments of Immunology and Neuroscience, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Tomoya KawamuraDepartments of Immunology and Neuroscience, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Manveen K SethiCenter for Biomedical Mass Spectrometry, Department of Biochemistry, Boston University School of Medicine, Boston, MA, 02118, USA.
Joseph ZaiaCenter for Biomedical Mass Spectrometry, Department of Biochemistry, Boston University School of Medicine, Boston, MA, 02118, USA.
Vez Repunte-CanonigoDepartments of Immunology and Neuroscience, The Scripps Research Institute, La Jolla, CA, 92037, USA.
Pietro Paolo SannaDepartments of Immunology and Neuroscience, The Scripps Research Institute, La Jolla, CA, 92037, USA. psanna@scripps.edu.ORCID 0000-0002-8307-2151
Scripps Research Institute · USBoston University · US

Funding

Systems biology of HIV, methamphetamine and antiretrovirals interactionsR01DA041750 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI KARAN, CHARLES, RISSMAN, ROBERT · 2016 to 2020
$4.4M
Proteoglycan Signaling as a New Therapeutic Target for Cocaine AddictionR01DA036241 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI SANNA, PIETRO P · 2014 to 2017
$1.7M
NIDA NIH HHS R01 DA036241NIDA NIH HHS R01 DA041750
6 · The paper itself

Abstract

Substance abuse is a pressing problem with few therapeutic options. The identification of addiction resilience factors is a potential strategy to identify new mechanisms that can be targeted therapeutically. Heparan sulfate (HS) is a linear sulfated polysaccharide that is a component of the cell surface and extracellular matrix. Heparan sulfate modulates the activity and distribution of a set of negatively charged signaling peptides and proteins - known as the HS interactome - by acting as a co-receptor or alternative receptor for growth factors and other signaling peptides and sequestering and localizing them, among other actions. Here, we show that stimulants like cocaine and methamphetamine greatly increase HS content and sulfation levels in the lateral hypothalamus and that HS contributes to the regulation of cocaine seeking and taking. The ability of the HS-binding neuropeptide glial-cell-line-derived neurotrophic factor (GDNF) to increase cocaine intake was potentiated by a deletion that abolished its HS binding. The delivery of heparanase, the endo-β-D-glucuronidase that degrades HS, accelerated the acquisition of cocaine self-administration and promoted persistent responding during extinction. Altogether, these results indicate that HS is a resilience factor for cocaine abuse and a novel therapeutic target for the treatment of cocaine addiction.

Indexed as

Molecular Targeted TherapyAnimalsBiological TransportCocaineCocaine-Related DisordersGlial Cell Line-Derived Neurotrophic FactorHeparan SulfateMaleMethamphetamineMiceTime FactorsCocaineGlial Cell Line-Derived Neurotrophic FactorHeparan SulfateMethamphetamine

Identifiers

PMID29066725
PMCPMC5654972
OpenAlexW2765585116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.